Skip to main content

Type of Inherited Blindness in Dogs

Genetic test could eradicate a type of inherited blindness in dogs



A mountain rescue dog whose duties ended after her eyesight failed has helped scientists create a test that could eradicate the genetic eye condition in her breed for good.

Shola the English shepherd has an inherited eye disease called progressive retinal atrophy (PRA) that causes the light-sensitive cells at the back of the eye to deteriorate, eventually leading to blindness.


PRA affects more than 100 dog breeds, can be caused by a number of different genetic variants and has no treatment. For some types, symptoms do not appear until the dog is several years old, by which point they may have passed their genes on to puppies.

Katherine Stanbury, the first author of the research from the University of Cambridge, said Shola was four years old when she began struggling with her vision in dim light.

“She was sent to a veterinary ophthalmologist and they confirmed that she had PRA,” said Stanbury. “And then it turned out her brother also had PRA.”

Stanbury and colleagues have not only identified the genetic variant responsible for the condition in English shepherds but developed a £48 DNA test to reveal whether dogs have none, one or two copies of the variant.

While Stanbury said variants that cause PRA were typically breed-specific, the team will now screen any dog affected by an inherited eye disease for the new variant.

“If it does pop up in another breed, we can monitor that,” she said.

The research began when Shola and her brother were brought to the team’s attention by their concerned breeder.

Writing in the journal Genes, Stanbury and colleagues reported how they carried out whole genome sequencing on the siblings’ DNA but found neither had genetic variants previously associated with PRA, suggesting a different variant was at play.

In a series of analyses using these genomes, as well as data on the genetic makeup of two additional English shepherds with PRA and 22 clear of eye disease, the team identified the variant responsible.

They hope the DNA test will enable owners to identify English shepherds with PRA early and avoid using them for breeding, raising the potential for PRA to be eliminated from the breed.

“You could still breed from a carrier [which has one copy of the variant], as long as you breed with a clear dog,” Stanbury said, adding that was important for genetic variation given the breed is relatively rare, especially in the UK.

She said the team had tested the father of Shola’s offspring, revealing the latter would not develop PRA.

“Two of her daughters have just completed their mountain rescue training with Mountain Rescue England,” said Stanbury. “And one of her sons is a therapy dog.”

Indeed one of the rescue dogs recently saved a man’s life. “[The owners] know that none of those dogs are going to go blind and have all that training be wasted,” Stanbury said.


inherited blindness, dog health, canine genetics, blind dogs, pet health, dog care, canine blindness, pet genetics, animal genetics, veterinary medicine, canine research, dog lovers, dog breeds, puppy care, dog wellness, genetic disorders, vision loss, dog eyes, animal welfare, veterinary science


International Conference on Genetics and Genomics of Diseases

Visit: genetics-conferences.healthcarek.com

Award Nomination: x-i.me/gennom1
Award registration: x-i.me/genreg2
Member Nomination: x-i.me/genmember
Member Registration: x-i.me/genreg1
For Enquiries: genetics@healthcarek.com


Get Connected Here
---------------------------------
---------------------------------

Pinterest: x-i.me/genpt
Twitter: x-i.me/gentw
Facebook: x-i.me/genfb
Instagram: x-i.me/genin
Youtube: x-i.me/genyt
Blogger: x-i.me/genbl


Comments

Popular posts from this blog

Fruitful innovation

Fruitful innovation: Transforming watermelon genetics with advanced base editors The development of new adenine base editors (ABE) and adenine-to-thymine/ guanine base editors (AKBE) is transforming watermelon genetic engineering. These innovative tools enable precise A:T-to-G and A:T-to-T base substitutions, allowing for targeted genetic modifications. The research highlights the efficiency of these editors in generating specific mutations, such as a flowerless phenotype in ClFT (Y84H) mutant plants. This advancement not only enhances the understanding of gene function but also significantly improves molecular breeding, paving the way for more efficient watermelon crop improvement. Traditional breeding methods for watermelon often face challenges in achieving desired genetic traits efficiently and accurately. While CRISPR/Cas9 has provided a powerful tool for genome editing, its precision and scope are sometimes limited. These limitations highlight the need for more advanced gene-e...

Genetic factors with clinical trial stoppage

Genetic factors associated with reasons for clinical trial stoppage Many drug discovery projects are started but few progress fully through clinical trials to approval. Previous work has shown that human genetics support for the therapeutic hypothesis increases the chance of trial progression. Here, we applied natural language processing to classify the free-text reasons for 28,561 clinical trials that stopped before their endpoints were met. We then evaluated these classes in light of the underlying evidence for the therapeutic hypothesis and target properties. We found that trials are more likely to stop because of a lack of efficacy in the absence of strong genetic evidence from human populations or genetically modified animal models. Furthermore, certain trials are more likely to stop for safety reasons if the drug target gene is highly constrained in human populations and if the gene is broadly expressed across tissues. These results support the growing use of human genetics to ...

Genetics study on COVID-19

Large genetic study on severe COVID-19 Bonn researchers confirm three other genes for increased risk in addition to the known TLR7 gene Whether or not a person becomes seriously ill with COVID-19 depends, among other things, on genetic factors. With this in mind, researchers from the University Hospital Bonn (UKB) and the University of Bonn, in cooperation with other research teams from Germany, the Netherlands, Spain and Italy, investigated a particularly large group of affected individuals. They confirmed the central and already known role of the TLR7 gene in severe courses of the disease in men, but were also able to find evidence for a contribution of the gene in women. In addition, they were able to show that genetic changes in three other genes of the innate immune system contribute to severe COVID-19. The results have now been published in the journal " Human Genetics and Genomics Advances ". Even though the number of severe cases following infection with the SARS-CoV-...